Trials / Completed
CompletedNCT07445217
Predictive Validity of the Personal and Social Performance Scale for PANSS Outcomes in Schizophrenia
Predictive Validity of the Personal and Social Performance Scale for PANSS Outcomes in Schizophrenia: a Severity-stratified Study
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 763 (actual)
- Sponsor
- Calo Psychiatric Center · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The Positive and Negative Syndrome Scale (PANSS) is a widely used instrument for assessing symptom severity in schizophrenia, whereas the Personal and Social Performance Scale (PSP) provides a practical measure of functional outcomes. This study aimed to evaluate the predictive validity of the PSP for PANSS outcomes in individuals with schizophrenia. A total of 763 patients diagnosed with schizophrenia and receiving paliperidone treatment were recruited in a 12-week multicenter prospective study. Among participants with a baseline PANSS score greater than 90, those with a 12-week PSP score above 60 were more likely to achieve a reduction of more than 20% in PANSS scores, whereas those with a PSP score below 60 showed less improvement.
Detailed description
This study employed a 12-week, multicenter, prospective research design focusing on the administration of the antipsychotic medication paliperidone. Assessments were conducted at baseline, week 4, and week 12. Two widely used scales-the PANSS and PSP-were utilized to evaluate patients before and after treatment, followed by a correlation analysis of the results.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | This study employed a 12-week, multicenter, prospective research design focusing on the administration of the antipsychotic medication paliperidone. | Assessments were conducted at baseline, week 4, and week 12. Two widely used scales-the PANSS and PSP-were utilized to evaluate patients before and after treatment, followed by a correlation analysis of the results. |
Timeline
- Start date
- 2008-03-10
- Primary completion
- 2008-06-01
- Completion
- 2008-09-04
- First posted
- 2026-03-03
- Last updated
- 2026-03-03
Locations
1 site across 1 country: Taiwan
Source: ClinicalTrials.gov record NCT07445217. Inclusion in this directory is not an endorsement.